The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Kumar Ramesh since 2013.
This trader's CIK number is 1580074.
At the time of last reporting, Kumar Ramesh was the Director of Ocugen, Inc.. (stock ticker symbol OCGN).
Also see all insider trading activities at Ocugen, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2017 | ONTX | 23,810 | $50,001 | 0 | $0 | 0 | $0 |
| 2014 | ONTX | 0 | $0 | 93,543 | $1,408,615 | 93,543 | $527,958 |
| 2013 | ONTX | 7,767 | $113,227 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2022 | OCGN | 0 | $0 | 27,000 | $79,260 | 27,000 | $13,770 |
| 2021 | OCGN | 0 | $0 | 22,500 | $148,950 | 22,500 | $11,475 |
1. Onconova Therapeutics, Inc. (ONTX)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2017-04-26 | ONTX | Buy | 23,810 | 2.10 | 50,001 |
| 2014-02-07 | ONTX | Option Ex | 13,543 | 6.00 | 81,258 |
| 2014-02-10 | ONTX | Option Ex | 20,000 | 6.00 | 120,000 |
| 2013-02-07 | ONTX | Sale | 13,543 | 15.02 | 203,415 |
| 2014-02-10 | ONTX | Sale | 20,000 | 15.11 | 302,200 |
| 2014-02-03 | ONTX | Sale | 20,000 | 15.07 | 301,400 |
| 2014-01-31 | ONTX | Sale | 20,000 | 15.03 | 300,600 |
| 2014-01-30 | ONTX | Sale | 20,000 | 15.05 | 301,000 |
| 2014-02-03 | ONTX | Option Ex | 20,000 | 6.00 | 120,000 |
| 2014-01-31 | ONTX | Option Ex | 20,000 | 6.00 | 120,000 |
| 2014-01-30 | ONTX | Option Ex | 20,000 | 4.33 | 86,700 |
| 2013-11-15 | ONTX | Buy | 1,100 | 12.02 | 13,222 |
| 2013-07-30 | ONTX | Buy | 6,667 | 15.00 | 100,005 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-10-06 | OCGN | Sale | 4,500 | 1.83 | 8,235 |
| 2022-10-06 | OCGN | Option Ex | 4,500 | .51 | 2,295 |
| 2022-07-18 | OCGN | Option Ex | 7,500 | .51 | 3,825 |
| 2022-07-18 | OCGN | Sale | 7,500 | 2.57 | 19,275 |
| 2022-04-18 | OCGN | Option Ex | 7,500 | .51 | 3,825 |
| 2022-04-18 | OCGN | Sale | 7,500 | 2.83 | 21,225 |
| 2022-01-18 | OCGN | Sale | 7,500 | 4.07 | 30,525 |
| 2022-01-18 | OCGN | Option Ex | 7,500 | .51 | 3,825 |
| 2021-10-18 | OCGN | Option Ex | 7,500 | .51 | 3,825 |
| 2021-10-18 | OCGN | Sale | 7,500 | 8.13 | 60,975 |
| 2021-07-19 | OCGN | Option Ex | 7,500 | .51 | 3,825 |
| 2021-07-19 | OCGN | Sale | 7,500 | 6.40 | 48,000 |
| 2021-04-19 | OCGN | Option Ex | 7,500 | .51 | 3,825 |
| 2021-04-19 | OCGN | Sale | 7,500 | 5.33 | 39,975 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Kumar Ramesh (Director of Ocugen, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.